BAHADIR GENİŞ - Academia.edu (original) (raw)

Papers by BAHADIR GENİŞ

PEARSON JOURNAL OF SOCIAL SCIENCES & HUMANITIES, 2020

Aim: The aim of this study is to develop scales that can enable to evaluate perceptions and attit... more Aim: The aim of this study is to develop scales that can enable to evaluate perceptions and attitudes associated with the outbreak during the COVID-19 pandemic. ___Materials and Methods: The research sample was composed of 352 healthcare workers and 507 non-healthcare workers. In the study, perceptions and attitudes regarding COVID-19 were evaluated on five scales: Perception of COVID-19 (P-COVID-19), Perception of Causes of COVID-19 (PCa-COVID-19), Perception of Control of COVID-19 (PCo-COVID-19), Avoidance Attitudes from COVID-19 (AA-COVID-19), and Attitudes Towards the COVID-19 Vaccine (ATV-COVID-19). In the study, scales were evaluated with appearance validity, content validity, structural validity (explanatory and confirmatory factor analysis) and Cronbach alpha internal reliability coefficients. ___Results: After the explanatory factor analysis, the scales were found to be suitable for factor analysis and had sub-dimensions. The P-COVID-19 scale had "Dangerousness" and "Contagiousness", the PCo-COVID-19 scale had "Macro Control", "Personal Control" and "Controllability", the PCaCOVID-19 scale had "Conspiracy", "Environment" and "Faith", the AA-COVID- 19 scale had "Cognitive" and "Behavioral avoidance", and the ATV-COVID-19 scale had "Positive" and "Negative Attitude" subscales. The determined subdimensions were evaluated by confirmatory factor analysis and good fit indexes were observed. Cronbach alpha coefficients were 0.74 for the P-COVID-19 scale, 0.79 for the PCo-COVID-19 scale, 0.88 for the PCa-COVID19 scale, 0.88 for the AA-COVID-19 scale, and 0.80 for the ATV-COVID-19 scale. ___Conclusion: When the validity and reliability analyze of the scales are evaluated together, it can be said that the scales have a valid and reliable structure that measures the perceptions and attitudes regarding COVID-19 both in healthcare workers and non-healthcare workers.

Türk Psikiyatri Dergisi, 2018

Bortezomib, an antineoplastic agent used in Multiple Myeloma, is a modified dipeptidyl boronic ac... more Bortezomib, an antineoplastic agent used in Multiple Myeloma, is a modified dipeptidyl boronic acid that is selectively and reversibly attached to the 26S proteasome. Bortezomib may be combined with corticosteroids in treatment-resistant multiple myeloma patients. Corticosteroids can cause many psychiatric disorders including mania, depression, psychosis, delirium, suicide and aggression. To date only one case of mania associated with the use of bortezomib was reported in which the patient responded to the treatment with olanzapine and valproic acid. In this article, we present a 57-year-old female with multiple myeloma in whom mania developed after the use of bortezomib combined with dexamethasone.Psychiatric symptoms such as sleep deprivation, increased self-esteem and excessive speech appeared within the first week of bortezomib and dexamethasone treatment. Quetiapine was administered for the treatment of psychiatric symptoms. A gradual improvement was noted in manic symptoms after treatment. Bortezomib is a relatively new drug and there are only a few reports with respect to its psychiatric side effects. While using antineoplastic drugs such as bortezomib, caution should be exercised with regards to the psychiatric symptoms.

Bağımlılık Dergisi, 2020

Objective: The aim of this study was to investigate the causes of long hospital stay in adult pat... more Objective: The aim of this study was to investigate the causes of long hospital stay in adult patients with alcohol use disorder inpatient treatment. Method: The study included the records of patients treated in the alcohol and drug addiction clinic of Gazi University Hospital between 2005 and 2016. The records of 1543 patients with alcohol dependence were reached. Only the first hospitalization data of patients with recurrent admission were included in the analysis. As a total the records of 906 patients were analyzed. Results: The mean age of the study population was 51.95±11.54 years and 89.4% (n = 810) were male. Recurrent hospitalization was 26.7% (n = 242), medical comorbidity 5% (n = 45), and psychiatric comorbidity 28% (n = 254). In the logistic regression analysis evaluating the duration of hospitalization, the presence of bipolar affective disorder (BDD) increased the duration of hospitalization by 3.4 times (OR=3.457), and the presence of depression extended the duration of hospitalization by 1.8 times (OR=1.854). The length of hospital stay of those hospitalized between 2014-2016 was 12 times (OR=0.082) shorter than those hospitalized between 2005-2007. Conclusion: Some clinical variables (age, BDD and depression) have been shown to affect the duration of hospitalization in alcohol dependence. Together with these clinical variables, a non-clinical variable, such as the year of hospitalization, was found to affect the length of hospital stay 12-fold. Moreover, this effect can increase up to 34 times. Keywords: Alcohol dependence, length of stay, alcohol use disorder, depression ÖZ Amaç: Bu çalışmada alkol kullanım bozukluğu olan yatarak tedavi gören erişkin hastalarda uzun süre hastanede kalış nedenlerini araştırılması amaçlanmıştır. Yöntem: Araştırmanın verileri, 2005-2016 yılları arasında Gazi Üniversitesi Hastanesi alkol ve uyuşturucu bağımlılığı kliniğinde tedavi edilen hastaların kayıtlarını içermektedir. Alkol bağımlılığı olan 1543 hastanın kayıtlarına ulaşılmıştır. Tekrarlayan başvuruları olan hastaların sadece ilk yatış verileri analize dahil edildi. 906 hastanın kayıtları analiz edildi. Bulgular: Çalışma popülasyonunun ortalama yaşı 51.95 ± 11.54 yıl idi ve% 89.4'ü (n = 810) erkekti. Tekrarlayan hastaneye yatış% 26.7 (n = 242), tıbbi eştanı% 5 (n = 45) ve psikiyatrik eştanı% 28 (n = 254) idi. Hastanede yatış süresini değerlendiren lojistik regresyon analizinde bipolar affektif bozukluğun (BDD) varlığı hastanede yatış süresini 3,4 kat (OR=3,457) arttırırken, depresyonun varlığı hastanede yatış süresini 1,8 kat (OR=1,854) artırdı. 2014-2016 yılları arasında hastaneye yatırılanların hastanede kalış süresi 2005-2007 yılları arasında hastaneye yatırılanlardan 12 kat (OR=0,082) daha kısaydı. Sonuç: Bazı klinik değişkenlerin (yaş, BDD ve depresyon) alkol bağımlılığında yatış süresini etkilediği gösterilmiştir. Bu klinik değişkenlerle birlikte, hastaneye yatış yılı gibi klinik olmayan bir değişkenin hastanede kalış süresini 12 kat etkilediği bulunmuştur. Ayrıca, bu etki 34 kata kadar artabilir. Anahtar kelimeler: Alkol bağımlılığı, yatış süresi, alkol kullanım bozukluğu, depresyon

PEARSON JOURNAL OF SOCIAL SCIENCES & HUMANITIES, 2020

Aim: The aim of this study is to develop scales that can enable to evaluate perceptions and attit... more Aim: The aim of this study is to develop scales that can enable to evaluate perceptions and attitudes associated with the outbreak during the COVID-19 pandemic. ___Materials and Methods: The research sample was composed of 352 healthcare workers and 507 non-healthcare workers. In the study, perceptions and attitudes regarding COVID-19 were evaluated on five scales: Perception of COVID-19 (P-COVID-19), Perception of Causes of COVID-19 (PCa-COVID-19), Perception of Control of COVID-19 (PCo-COVID-19), Avoidance Attitudes from COVID-19 (AA-COVID-19), and Attitudes Towards the COVID-19 Vaccine (ATV-COVID-19). In the study, scales were evaluated with appearance validity, content validity, structural validity (explanatory and confirmatory factor analysis) and Cronbach alpha internal reliability coefficients. ___Results: After the explanatory factor analysis, the scales were found to be suitable for factor analysis and had sub-dimensions. The P-COVID-19 scale had "Dangerousness" and "Contagiousness", the PCo-COVID-19 scale had "Macro Control", "Personal Control" and "Controllability", the PCaCOVID-19 scale had "Conspiracy", "Environment" and "Faith", the AA-COVID- 19 scale had "Cognitive" and "Behavioral avoidance", and the ATV-COVID-19 scale had "Positive" and "Negative Attitude" subscales. The determined subdimensions were evaluated by confirmatory factor analysis and good fit indexes were observed. Cronbach alpha coefficients were 0.74 for the P-COVID-19 scale, 0.79 for the PCo-COVID-19 scale, 0.88 for the PCa-COVID19 scale, 0.88 for the AA-COVID-19 scale, and 0.80 for the ATV-COVID-19 scale. ___Conclusion: When the validity and reliability analyze of the scales are evaluated together, it can be said that the scales have a valid and reliable structure that measures the perceptions and attitudes regarding COVID-19 both in healthcare workers and non-healthcare workers.

Türk Psikiyatri Dergisi, 2018

Bortezomib, an antineoplastic agent used in Multiple Myeloma, is a modified dipeptidyl boronic ac... more Bortezomib, an antineoplastic agent used in Multiple Myeloma, is a modified dipeptidyl boronic acid that is selectively and reversibly attached to the 26S proteasome. Bortezomib may be combined with corticosteroids in treatment-resistant multiple myeloma patients. Corticosteroids can cause many psychiatric disorders including mania, depression, psychosis, delirium, suicide and aggression. To date only one case of mania associated with the use of bortezomib was reported in which the patient responded to the treatment with olanzapine and valproic acid. In this article, we present a 57-year-old female with multiple myeloma in whom mania developed after the use of bortezomib combined with dexamethasone.Psychiatric symptoms such as sleep deprivation, increased self-esteem and excessive speech appeared within the first week of bortezomib and dexamethasone treatment. Quetiapine was administered for the treatment of psychiatric symptoms. A gradual improvement was noted in manic symptoms after treatment. Bortezomib is a relatively new drug and there are only a few reports with respect to its psychiatric side effects. While using antineoplastic drugs such as bortezomib, caution should be exercised with regards to the psychiatric symptoms.

Bağımlılık Dergisi, 2020

Objective: The aim of this study was to investigate the causes of long hospital stay in adult pat... more Objective: The aim of this study was to investigate the causes of long hospital stay in adult patients with alcohol use disorder inpatient treatment. Method: The study included the records of patients treated in the alcohol and drug addiction clinic of Gazi University Hospital between 2005 and 2016. The records of 1543 patients with alcohol dependence were reached. Only the first hospitalization data of patients with recurrent admission were included in the analysis. As a total the records of 906 patients were analyzed. Results: The mean age of the study population was 51.95±11.54 years and 89.4% (n = 810) were male. Recurrent hospitalization was 26.7% (n = 242), medical comorbidity 5% (n = 45), and psychiatric comorbidity 28% (n = 254). In the logistic regression analysis evaluating the duration of hospitalization, the presence of bipolar affective disorder (BDD) increased the duration of hospitalization by 3.4 times (OR=3.457), and the presence of depression extended the duration of hospitalization by 1.8 times (OR=1.854). The length of hospital stay of those hospitalized between 2014-2016 was 12 times (OR=0.082) shorter than those hospitalized between 2005-2007. Conclusion: Some clinical variables (age, BDD and depression) have been shown to affect the duration of hospitalization in alcohol dependence. Together with these clinical variables, a non-clinical variable, such as the year of hospitalization, was found to affect the length of hospital stay 12-fold. Moreover, this effect can increase up to 34 times. Keywords: Alcohol dependence, length of stay, alcohol use disorder, depression ÖZ Amaç: Bu çalışmada alkol kullanım bozukluğu olan yatarak tedavi gören erişkin hastalarda uzun süre hastanede kalış nedenlerini araştırılması amaçlanmıştır. Yöntem: Araştırmanın verileri, 2005-2016 yılları arasında Gazi Üniversitesi Hastanesi alkol ve uyuşturucu bağımlılığı kliniğinde tedavi edilen hastaların kayıtlarını içermektedir. Alkol bağımlılığı olan 1543 hastanın kayıtlarına ulaşılmıştır. Tekrarlayan başvuruları olan hastaların sadece ilk yatış verileri analize dahil edildi. 906 hastanın kayıtları analiz edildi. Bulgular: Çalışma popülasyonunun ortalama yaşı 51.95 ± 11.54 yıl idi ve% 89.4'ü (n = 810) erkekti. Tekrarlayan hastaneye yatış% 26.7 (n = 242), tıbbi eştanı% 5 (n = 45) ve psikiyatrik eştanı% 28 (n = 254) idi. Hastanede yatış süresini değerlendiren lojistik regresyon analizinde bipolar affektif bozukluğun (BDD) varlığı hastanede yatış süresini 3,4 kat (OR=3,457) arttırırken, depresyonun varlığı hastanede yatış süresini 1,8 kat (OR=1,854) artırdı. 2014-2016 yılları arasında hastaneye yatırılanların hastanede kalış süresi 2005-2007 yılları arasında hastaneye yatırılanlardan 12 kat (OR=0,082) daha kısaydı. Sonuç: Bazı klinik değişkenlerin (yaş, BDD ve depresyon) alkol bağımlılığında yatış süresini etkilediği gösterilmiştir. Bu klinik değişkenlerle birlikte, hastaneye yatış yılı gibi klinik olmayan bir değişkenin hastanede kalış süresini 12 kat etkilediği bulunmuştur. Ayrıca, bu etki 34 kata kadar artabilir. Anahtar kelimeler: Alkol bağımlılığı, yatış süresi, alkol kullanım bozukluğu, depresyon